Raysearch Laboratories Ab Stock Performance
| RSLBF Stock | USD 23.00 0.00 0.00% |
The company holds a Beta of 0.0445, which implies not very significant fluctuations relative to the market. As returns on the market increase, RaySearch Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding RaySearch Laboratories is expected to be smaller as well. At this point, RaySearch Laboratories has a negative expected return of -0.29%. Please make sure to check RaySearch Laboratories' treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if RaySearch Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days RaySearch Laboratories AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 168.7 M | |
| Total Cashflows From Investing Activities | -237.6 M |
RaySearch |
RaySearch Laboratories Relative Risk vs. Return Landscape
If you would invest 2,761 in RaySearch Laboratories AB on November 14, 2025 and sell it today you would lose (461.00) from holding RaySearch Laboratories AB or give up 16.7% of portfolio value over 90 days. RaySearch Laboratories AB is currently producing negative expected returns and takes up 1.3589% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than RaySearch, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
RaySearch Laboratories Target Price Odds to finish over Current Price
The tendency of RaySearch Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 23.00 | 90 days | 23.00 | about 91.81 |
Based on a normal probability distribution, the odds of RaySearch Laboratories to move above the current price in 90 days from now is about 91.81 (This RaySearch Laboratories AB probability density function shows the probability of RaySearch Pink Sheet to fall within a particular range of prices over 90 days) .
RaySearch Laboratories Price Density |
| Price |
Predictive Modules for RaySearch Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as RaySearch Laboratories. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.RaySearch Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. RaySearch Laboratories is not an exception. The market had few large corrections towards the RaySearch Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold RaySearch Laboratories AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of RaySearch Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.04 | |
σ | Overall volatility | 2.04 | |
Ir | Information ratio | -0.29 |
RaySearch Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RaySearch Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RaySearch Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RaySearch Laboratories generated a negative expected return over the last 90 days | |
| The company reported the revenue of 641.67 M. Net Loss for the year was (47.31 M) with profit before overhead, payroll, taxes, and interest of 591.28 M. | |
| About 56.0% of the company shares are owned by institutional investors |
RaySearch Laboratories Fundamentals Growth
RaySearch Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of RaySearch Laboratories, and RaySearch Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RaySearch Pink Sheet performance.
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.01) % | |||
| Current Valuation | 237.19 M | |||
| Shares Outstanding | 25.83 M | |||
| Price To Earning | 31.16 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 3.02 X | |||
| Revenue | 641.67 M | |||
| EBITDA | 197.36 M | |||
| Cash And Equivalents | 5.96 M | |||
| Cash Per Share | 0.17 X | |||
| Total Debt | 13.74 M | |||
| Debt To Equity | 0.80 % | |||
| Book Value Per Share | 2.05 X | |||
| Cash Flow From Operations | 238.16 M | |||
| Total Asset | 1.74 B | |||
| Current Asset | 319 M | |||
| Current Liabilities | 96 M | |||
About RaySearch Laboratories Performance
By analyzing RaySearch Laboratories' fundamental ratios, stakeholders can gain valuable insights into RaySearch Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if RaySearch Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if RaySearch Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
RaySearch Laboratories AB , a medical technology company, develops software solutions for cancer treatment worldwide. RaySearch Laboratories AB is headquartered in Stockholm, Sweden. Raysearch Laboratories operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 389 people.Things to note about RaySearch Laboratories performance evaluation
Checking the ongoing alerts about RaySearch Laboratories for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for RaySearch Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RaySearch Laboratories generated a negative expected return over the last 90 days | |
| The company reported the revenue of 641.67 M. Net Loss for the year was (47.31 M) with profit before overhead, payroll, taxes, and interest of 591.28 M. | |
| About 56.0% of the company shares are owned by institutional investors |
- Analyzing RaySearch Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RaySearch Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining RaySearch Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RaySearch Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of RaySearch Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RaySearch Laboratories' pink sheet. These opinions can provide insight into RaySearch Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for RaySearch Pink Sheet analysis
When running RaySearch Laboratories' price analysis, check to measure RaySearch Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RaySearch Laboratories is operating at the current time. Most of RaySearch Laboratories' value examination focuses on studying past and present price action to predict the probability of RaySearch Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RaySearch Laboratories' price. Additionally, you may evaluate how the addition of RaySearch Laboratories to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |